<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="protease RBD receptor binding domain RBM receptor binding motif RBV" exact="ribavirin" post="RdRP RNAâ€�dependent RNA polymerase SARSâ€�CoV severe acute respiratory syndrome"/>
 <result pre="A recent hypothesis proposed that ACE inhibitors (ACEIs), such as" exact="captopril" post="and enalapril, or angiotensin AT1 receptor antagonists, including losartan"/>
 <result pre="an in vitro study found that the serine protease inhibitor" exact="camostat" post="mesylate could significantly block the activity of TMPRSS2, which"/>
 <result pre="therapeutic target for the treatment of SARSâ€�CoVâ€�2â€�infected patients. More remarkably," exact="camostat" post="mesylate has already been approved for safety for the"/>
 <result pre="of pancreatic inflammatory disease in Japan, which reminds us that" exact="camostat" post="mesylate should be given sufficient consideration as a promising"/>
 <result pre="finding from the University of Tokyo, a comparable drug named" exact="nafamostat" post="mesylate can prevent TMPRSS2â€�triggered SARSâ€�CoVâ€�2 membrane fusion at a"/>
 <result pre="membrane fusion at a concentration less than oneâ€�tenth that of" exact="camostat" post="mesylate, suggesting that nafamostat mesylate may also be a"/>
 <result pre="concentration less than oneâ€�tenth that of camostat mesylate, suggesting that" exact="nafamostat" post="mesylate may also be a promising inhibitor of SARSâ€�CoVâ€�2"/>
 <result pre="He, 2005), which indicates its potential for antiâ€�SARSâ€�CoVâ€�2 drug development." exact="Ribavirin" post="(RBV), a broadâ€�spectrum antiviral drug, has been studied in"/>
 <result pre="St, &amp;amp; Mesecar, 2015). The identified 6â€�mercaptopurine, 6â€�thioguanine, Nâ€�ethylmaleimide, and" exact="mycophenolic acid" post="could act as MERSâ€�CoV PLpro inhibitors to suppress its"/>
 <result pre="SARSâ€�CoV patients (Wu et al., 2004). Based on these results," exact="lopinavir" post="and ritonavir may also be promising drugs for SARSâ€�CoVâ€�2"/>
 <result pre="(Wu et al., 2004). Based on these results, lopinavir and" exact="ritonavir" post="may also be promising drugs for SARSâ€�CoVâ€�2 treatment. Interestingly,"/>
 <result pre="drugs for SARSâ€�CoVâ€�2 treatment. Interestingly, treatment with a formulation of" exact="lopinavir" post="and ritonavir in tablet form (800/200 mgÂ·dayâˆ’1) called Kaletra"/>
 <result pre="SARSâ€�CoVâ€�2 treatment. Interestingly, treatment with a formulation of lopinavir and" exact="ritonavir" post="in tablet form (800/200 mgÂ·dayâˆ’1) called Kaletra can quickly"/>
 <result pre="of lopinavir and ritonavir in tablet form (800/200 mgÂ·dayâˆ’1) called" exact="Kaletra" post="can quickly improve clinical symptoms by inhibiting SARSâ€�CoVâ€�2 replication"/>
 <result pre="silico and enzyme activity test) on January 25, 2020, including" exact="lopinavir" post="and ritonavir. Even though this combination has produced a"/>
 <result pre="to test the effectiveness of HIV protease inhibitors such as" exact="lopinavir" post="and ritonavir in patients infected with SARSâ€�CoVâ€�2. However, an"/>
 <result pre="the effectiveness of HIV protease inhibitors such as lopinavir and" exact="ritonavir" post="in patients infected with SARSâ€�CoVâ€�2. However, an increasing number"/>
 <result pre="et al., 2020). Although hopes are fading for treatment with" exact="lopinavir" post="and ritonavir, targeting 3CLpro is still a potential therapeutic"/>
 <result pre="I. H., â€¦ Chou, C. Y. (2015). Thiopurine analogs and" exact="mycophenolic acid" post="synergistically inhibit the papainâ€�like protease of Middle East respiratory"/>
 <result pre="protease. PLoS Pathogens, 10(5), 1â€&quot;15. e100411310.1371/journal.ppat.1004113 RIddell, S. R. (2018)." exact="Adrenaline" post="fuels a cytokine storm during immunotherapy. Nature, 564(7735), 194â€&quot;196."/>
 <result pre="in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or" exact="methotrexate" post="monotherapy. Annals of the Rheumatic Diseases, 79(4), 460â€&quot;463. 10.1136/annrheumdis-2019-21653732033935"/>
 <result pre="(2019). Initiating tocilizumab, with or without methotrexate, compared with starting" exact="methotrexate" post="with prednisone within stepâ€�up treatment strategies in early rheumatoid"/>
 <result pre="tocilizumab, with or without methotrexate, compared with starting methotrexate with" exact="prednisone" post="within stepâ€�up treatment strategies in early rheumatoid arthritis: An"/>
 <result pre="Liu, J., Xu, M., â€¦ Xiao, G. (2020). Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019â€�nCoV) in"/>
</results>
